Wordt geladen...
BAYESIAN PHASE I/II ADAPTIVELY RANDOMIZED ONCOLOGY TRIALS WITH COMBINED DRUGS
We propose a new integrated phase I/II trial design to identify the most efficacious dose combination that also satisfies certain safety requirements for drug-combination trials. We first take a Bayesian copula-type model for dose finding in phase I. After identifying a set of admissible doses, we i...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3286607/ https://ncbi.nlm.nih.gov/pubmed/22375162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1214/10-AOAS433 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|